Pioglitazone attenuates kidney injury in an experimental model of gentamicin-induced nephrotoxicity in rats
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pioglitazone attenuates kidney injury in an experimental model of gentamicin-induced nephrotoxicity in rats
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-23
DOI
10.1038/s41598-019-49835-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pioglitazone, a Peroxisome Proliferator-Activated Receptor γ Agonist, Ameliorates Chronic Kidney Disease by Enhancing Antioxidative Capacity and Attenuating Angiogenesis in the Kidney of a 5/6 Nephrectomized Rat Model
- (2016) Li Sun et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Evaluation of KIM-1 and NGAL as Early Indicators for Assessment of Gentamycin-Induced Nephrotoxicity In Vivo and In Vitro
- (2016) Qi-Hui Luo et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Pioglitazone ameliorates renal ischemia reperfusion injury through NMDA receptor antagonism in rats
- (2016) Amrit Pal Singh et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Pioglitazone Enhances the Beneficial Effects of Glucocorticoids in Experimental Nephrotic Syndrome
- (2016) S. Agrawal et al. Scientific Reports
- Additive Renoprotection by Pioglitazone and Fenofibrate against Inflammatory, Oxidative and Apoptotic Manifestations of Cisplatin Nephrotoxicity: Modulation by PPARs
- (2015) Mai M. Helmy et al. PLoS One
- The Nephroprotective Effects of Pioglitazone and Glibenclamide Against Gentamicin-Induced Nephrotoxicity in Rats: A Comparative Study
- (2014) S. I. Al-Azzam et al. JOURNAL OF CHEMOTHERAPY
- KIM-1 and NGAL as biomarkers of nephrotoxicity induced by gentamicin in rats
- (2014) Qi-hui Luo et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Cilostazol Renoprotective Effect: Modulation of PPAR-γ, NGAL, KIM-1 and IL-18 Underlies Its Novel Effect in a Model of Ischemia-Reperfusion
- (2014) Diaa Ragab et al. PLoS One
- Pioglitazone protects against renal ischemia-reperfusion injury by enhancing antioxidant capacity
- (2013) Cong Zou et al. JOURNAL OF SURGICAL RESEARCH
- The effects of PPAR-γ agonist pioglitazone on renal ischemia/reperfusion injury in rats
- (2012) Buket Reel et al. JOURNAL OF SURGICAL RESEARCH
- Losartan and Pioglitazone Ameliorate Nephropathy in Experimental Metabolic Syndrome Rats
- (2011) Xiang Kong et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- The PPAR Agonist Pioglitazone Ameliorates Aging-Related Progressive Renal Injury
- (2009) H.-C. Yang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Peroxisome Proliferator-Activated Receptor Gamma Agonists in Kidney Disease – Future Promise, Present Fears
- (2009) Zhiguo Mao et al. NEPHRON CLINICAL PRACTICE
- PPAR-γ agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-β
- (2008) Toru Kawai et al. LABORATORY INVESTIGATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started